Hillchol: Bharat Biotech’s oral cholera vaccine demonstrates success in phase III clinical studies EP News Bureau May 21, 2025 Hillchol has demonstrated against both Ogawa and Inaba serotypes, and aims to address the global shortage of cholera vaccines
